Comparative Analysis of National Drug Policies - Second Workshop Geneva, 10-13 June 1996 - EDM Research Series No. 025
(1997; 175 pages) View the PDF document
Table of Contents
View the documentExecutive summary
View the documentI. Introduction
Open this folder and view contentsII. Background on the research project
Open this folder and view contentsIII. Second workshop
Open this folder and view contentsIV. Preliminary findings
Open this folder and view contentsV. Conclusions of the workshop and follow-up plans
Close this folderAnnex 1: Research proposal
View the documentI. Introduction
View the documentII. The Problem
View the documentIII. Research Question and Objectives of Proposed Study
View the documentIV. Study Approach
View the documentV. Anticipated Outcomes
View the documentVI. Methods
View the documentVII. Time Line and Resources
View the documentSelected References
View the documentAnnex 2: List of participants
View the documentAnnex 3: Agenda
View the documentAnnex 4: Questionnaire on NDP performance assessment
Open this folder and view contentsAnnex 5: Achievements of the national drug policies in the 12 countries
View the documentAnnex 6: Consolidated tables
View the documentOther documents in the DAP Research Series

III. Research Question and Objectives of Proposed Study

The overall goal of the project is to assess the performance of national pharmaceutical policies in developing countries (focusing on policy outputs and policy process), to analyze the reasons for their success or failure, and to propose strategies for improvement. The principal research question that the project seeks to answer is: Have National Drug Policies (whether they exist as explicit policy documents, or are implicit in government actions) in developing countries been successful in achieving the goals of availability, accessibility, good quality, and rational use of essential drugs? Why or why not?

The project will combine several disciplines (policy analysis, economics, and epidemiology/medicine/pharmacy) in order to assess national accomplishments, and develop fresh perspectives on national and international initiatives. Attention will be given, where warranted, to the interaction of public and private sectors in the pharmaceutical field of each country. Within this context, the specific objectives are:

a) To identify strengths, weaknesses, and political dimensions of pharmaceutical policy formulation and implementation within each country;

b) To propose explanations for cross-national variations in performance; and

c) To propose effective strategies, both national and international, that can improve pharmaceutical policy implementation.

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017